Shi‐Shan Mao

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

Jia-Tsrong Jan, Ting-Jen Rachel Cheng, Yu-Pu Juang et al. · Proceedings of the National Academy of Sciences · 2021 · 184 citations · Full text

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

John A. McCauley, Charles McIntyre, Michael T. Rudd et al. · Journal of Medicinal Chemistry · 2010 · 176 citations

Immunology, Antiviral Drug, Medicinal Chemistry +17

Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease

Nigel J. Liverton, M. Katharine Holloway, John A. McCauley et al. · Journal of the American Chemical Society · 2008 · 134 citations

Molecular Docking, Medicinal Chemistry, Initial Compounds +14

Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

Shi‐Shan Mao, Carolyn M. Cooper, Theresa Wood et al. · Journal of Biological Chemistry · 1999 · 131 citations · Full text

Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position

Dong-Mei Feng, Stephen J. Gardell, Sidney D. Lewis et al. · Journal of Medicinal Chemistry · 1997 · 57 citations · Full text